S. Lagercrantz

发表

Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern.

J. Gustafsson, K. Grandien, M. Nordenskjöld, 1997, The Journal of clinical endocrinology and metabolism.

Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia

V. P. Collins, C. Larsson, E. Thelander, 2008, Leukemia & lymphoma.

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes

E. Schröck, C. Lázaro, G. Capellá, 2018, Familial Cancer.

Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma

C. Larsson, R. Rosenquist, R. Amini, 2007, Modern Pathology.

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer : tumor heterogeneity should be taken into consideration

Yan Wang, K. Mu, S. Lagercrantz, 2015 .

Expression of the p53 Target Wig-1 Is Associated with HPV Status and Patient Survival in Cervical Carcinoma

C. Larsson, D. Grandér, K. Wiman, 2014, PloS one.

Characterization and chromosomal localization of the human insulin-like growth factor-binding protein 6 gene

C. Larsson, H. Luthman, S. Lagercrantz, 1999, Mammalian Genome.

Cloning, expression pattern, and chromosomal assignment to 16q23 of the human γ-adaptin gene (ADTG)

J. Dumanski, M. Peyrard, I. Fransson, 1998 .

Cloning and characterization of freac-9 (FKHL17), a novel kidney-expressed human forkhead gene that maps to chromosome 1p32-p34.

C. Larsson, P. Carlsson, S. Enerbäck, 1997, Genomics.

Aberrations of centrosomes in adrenocortical tumors.

C. Larsson, G. Auer, K. Fujioka, 2002, International journal of oncology.

Eva Enmark, Markku Pelto-Huikko, Kaj Grandien, 2022 .

Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.

S. Eriksson, S. Lagercrantz, J. Liliemark, 2003, Biochemical pharmacology.

Chromosome localization, sequence analysis, and expression pattern identify FKHL 18 as a novel human forkhead gene.

C. Larsson, M. Hulander, P. Carlsson, 1997, Genomics.

Gain of 1q and loss of 9q21.3‐q32 are associated with a less favorable prognosis in papillary thyroid carcinoma

C. Larsson, J. Zedenius, G. Wallin, 2001, Genes, chromosomes & cancer.

U‐2940, a human B‐cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma

B. Glimelius, G. Enblad, C. Sundström, 2006, International journal of cancer.

Spontaneously immortalized human T lymphocytes develop gain of chromosomal region 2p13–24 as an early and common genetic event

C. Larsson, E. Blennow, K. Chrzanowska, 2004, Genes, chromosomes & cancer.

Reply to Kratz et al.

E. Schröck, D. Evans, C. Lázaro, 2020, European Journal of Human Genetics.

Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism.

C. Larsson, S. Lagercrantz, F. Farnebo, 2001, European journal of endocrinology.

Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma.

C. Larsson, R. Rosenquist, K. Ichimura, 2007, Leukemia research.

Amplification of 2p as a Genomic Marker for Transformation in Lymphoma

A. Kwiecińska, C. Larsson, K. Ichimura, 2014, Genes, chromosomes & cancer.

A Novel B-cell Line (U-2932) Established from a Patient with Diffuse Large B-cell Lymphoma Following Hodgkin Lymphoma

J. Bergh, R. Rosenquist, R. Amini, 2002, Leukemia & lymphoma.

Chromosomal Imbalances in Diffuse Large B-Cell Lymphoma Detected by Comparative Genomic Hybridization

Göran Roos, Svetlana Lagercrantz, Richard Rosenquist, 2002, Modern Pathology.

Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

R. Amini, A. Wingren, O. Söderberg, 2007, Leukemia & lymphoma.

A standardized method for quantifying proliferation by Ki-67 and cyclin A immunohistochemistry in breast cancer.

A. Zetterberg, G. Auer, D. Ye, 2015, Annals of diagnostic pathology.

Mantle cell lymphomas with clonal immunoglobulin VH3–21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin VH genes

C. Larsson, E. Thelander, R. Rosenquist, 2005, Modern Pathology.

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy

C. Larsson, M. Jeddi-Tehrani, F. Shokri, 2008, International journal of cancer.

Evaluation of spectral karyotyping (SKY) in biodosimetry for the triage situation following gamma irradiation

C. Larsson, R. Lewensohn, S. Lagercrantz, 2006, International journal of radiation biology.

Mapping of the human Ca2+ channel β4 subunit to 2q22-23 and its expression in developing mouse

C. Larsson, F. Piehl, R. Betz, 1998, Mammalian Genome.

Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma.

C. Larsson, W. Lui, G. Enblad, 2003, Cancer genetics and cytogenetics.

Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.

A. Zetterberg, C. Larsson, U. Bergerheim, 2004, International journal of oncology.

Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.

T. Dwight, C. Larsson, W. Lui, 2005, International journal of oncology.

Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization.

C. Larsson, R. Rosenquist, M. Erlanson, 2002, Cancer genetics and cytogenetics.

Cloning, expression pattern, and chromosomal assignment to 16q23 of the human gamma-adaptin gene (ADTG).

J. Dumanski, M. Peyrard, I. Fransson, 1998, Genomics.

New chromosomal breakpoints in non-Hodgkin's lymphomas revealed by spectral karyotyping and G-banding.

C. Larsson, A. Nordgren, E. Blennow, 2000, International journal of molecular medicine.